Nanobubble Liposome Complexes for Diagnostic Imaging and Ultrasound-Triggered Drug Delivery in Cancers: A Theranostic Approach

Overview

Journal ACS Omega

Publisher American Chemical Society

Specialty Chemistry

Date 2019 Oct 2

PMID 31572858

Citations 29

Authors

Ameya Prabhakar

Rinti Banerjee

Affiliations

Soon will be listed here.

Abstract

The ability of ultrasound contrast agents to enhance the cell membrane permeability in response to an ultrasound pulse has unveiled avenues to facilitate the delivery of a higher intracellular payload at target sites. In light of the above, we report the development of submicron-sized (528.7 ± 31.7 nm) nanobubble-paclitaxel liposome (NB-PTXLp) complexes for ultrasound imaging and ultrasound responsive drug delivery in cancer cells. With a paclitaxel entrapment efficiency of 85.4 ± 4.39%, the 200 nm-sized liposomes tethered efficiently (conjugation efficiency ∼98.7 ± 0.14%) with the nanobubbles to form conjugates. Sonoporation of MiaPaCa-2 cells upon treatment with nanobubbles and ultrasound enhanced cellular permeability, resulting in 2.5-fold higher uptake of liposomes in comparison to only liposome treatment. This manifested into more than 300-fold higher anticancer activity of NB-PTXLps in the presence of ultrasound in MiaPaCa-2, Panc-1, MDA-MB-231, and AW-8507 cell lines, compared to commercial formulation ABRAXANE. Also, the NB-PTXLp conjugates were found to exhibit echogenicity comparable to the commercial ultrasound contrast agent SonoVue. In addition, the developed nanobubbles were found to exhibit more than 1 week echogenic stability as opposed to 6 h stability of the commercially available ultrasound contrast agent SonoVue. Hence, the NB-PTXLps developed herein could prove to be a promising and minimally invasive theranostic platform for cancer treatments in the future.

Citing Articles

A state-of-the-art review of the recent advances of theranostic liposome hybrid nanoparticles in cancer treatment and diagnosis.

Azimizonuzi H, Ghayourvahdat A, Ahmed M, Kareem R, Jaber Zrzor A, Mansoor A Cancer Cell Int. 2025; 25(1):26.

PMID: 39871316 PMC: 11773959. DOI: 10.1186/s12935-024-03610-z.

Nanobubble Contrast Enhanced Ultrasound Imaging: A Review.

Wegierak D, Nittayacharn P, Cooley M, Berg F, Kosmides T, Durig D Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(6):e2007.

PMID: 39511794 PMC: 11567054. DOI: 10.1002/wnan.2007.

Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies.

Zhang Y, Tian J ACS Omega. 2024; 9(36):37459-37504.

PMID: 39281920 PMC: 11391544. DOI: 10.1021/acsomega.4c04573.

Enhancing Curcumin's therapeutic potential in cancer treatment through ultrasound mediated liposomal delivery.

Radha R, Paul V, Anjum S, Bouakaz A, Pitt W, Husseini G Sci Rep. 2024; 14(1):10499.

PMID: 38714740 PMC: 11076529. DOI: 10.1038/s41598-024-61278-x.

Biomedical Approach of Nanotechnology and Biological Risks: A Mini-Review.

Silva D, Melo A, Uchoa A, Pereira G, Alves A, Vasconcellos M Int J Mol Sci. 2023; 24(23).

PMID: 38069043 PMC: 10706257. DOI: 10.3390/ijms242316719.

References

Boissenot T, Bordat A, Fattal E, Tsapis N . Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications. J Control Release. 2016; 241:144-163. DOI: 10.1016/j.jconrel.2016.09.026. View

Dijkmans P, Juffermans L, Musters R, van Wamel A, Ten Cate F, van Gilst W . Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiogr. 2004; 5(4):245-56. DOI: 10.1016/j.euje.2004.02.001. View

Centelles M, Wright M, So P, Amrahli M, Xu X, Stebbing J . Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours. J Control Release. 2018; 280:87-98. DOI: 10.1016/j.jconrel.2018.04.047. View

Basta G, Venneri L, Lazzerini G, Pasanisi E, Pianelli M, Vesentini N . In vitro modulation of intracellular oxidative stress of endothelial cells by diagnostic cardiac ultrasound. Cardiovasc Res. 2003; 58(1):156-61. DOI: 10.1016/s0008-6363(02)00665-x. View

Yoon H, Selvan S, Yang Y, Kim M, Yi D, Kwon I . Engineering nanoparticle strategies for effective cancer immunotherapy. Biomaterials. 2018; 178:597-607. DOI: 10.1016/j.biomaterials.2018.03.036. View

Moros M, Idiago-Lopez J, Asin L, Moreno-Antolin E, Beola L, Grazu V . Triggering antitumoural drug release and gene expression by magnetic hyperthermia. Adv Drug Deliv Rev. 2018; 138:326-343. DOI: 10.1016/j.addr.2018.10.004. View

Wang D, Yang K, Gao Y, Tan K, Liu Z . Preparation and characterization of a nanoscale ultrasound contrast agent. Clin Imaging. 2010; 34(4):288-92. DOI: 10.1016/j.clinimag.2010.02.009. View

Ezrahi S, Aserin A, Garti N . Basic principles of drug delivery systems - the case of paclitaxel. Adv Colloid Interface Sci. 2018; 263:95-130. DOI: 10.1016/j.cis.2018.11.004. View

Ling L, Du Y, Ismail M, He R, Hou Y, Fu Z . Self-assembled liposomes of dual paclitaxel-phospholipid prodrug for anticancer therapy. Int J Pharm. 2017; 526(1-2):11-22. DOI: 10.1016/j.ijpharm.2017.04.024. View

10.

Cosgrove C, Salani R . Ovarian effects of radiation and cytotoxic chemotherapy damage. Best Pract Res Clin Obstet Gynaecol. 2018; 55:37-48. DOI: 10.1016/j.bpobgyn.2018.07.008. View

11.

Ninomiya K, Yamashita T, Tanabe Y, Imai M, Takahashi K, Shimizu N . Targeted and ultrasound-triggered cancer cell injury using perfluorocarbon emulsion-loaded liposomes endowed with cancer cell-targeting and fusogenic capabilities. Ultrason Sonochem. 2015; 28:54-61. DOI: 10.1016/j.ultsonch.2015.06.032. View

12.

Tao J, Visvanathan K, Wolff A . Long term side effects of adjuvant chemotherapy in patients with early breast cancer. Breast. 2015; 24 Suppl 2:S149-53. PMC: 4743500. DOI: 10.1016/j.breast.2015.07.035. View

13.

McIlvain G, Ganji E, Cooper C, Killian M, Ogunnaike B, Johnson C . Reliable preparation of agarose phantoms for use in quantitative magnetic resonance elastography. J Mech Behav Biomed Mater. 2019; 97:65-73. PMC: 6699912. DOI: 10.1016/j.jmbbm.2019.05.001. View

14.

Yang J, Zhai S, Qin H, Yan H, Xing D, Hu X . NIR-controlled morphology transformation and pulsatile drug delivery based on multifunctional phototheranostic nanoparticles for photoacoustic imaging-guided photothermal-chemotherapy. Biomaterials. 2018; 176:1-12. DOI: 10.1016/j.biomaterials.2018.05.033. View

15.

Mura S, Nicolas J, Couvreur P . Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013; 12(11):991-1003. DOI: 10.1038/nmat3776. View

16.

van Wamel A, Kooiman K, Harteveld M, Emmer M, Ten Cate F, Versluis M . Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release. 2006; 112(2):149-55. DOI: 10.1016/j.jconrel.2006.02.007. View

17.

Cochran M, Eisenbrey J, Ouma R, Soulen M, Wheatley M . Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm. 2011; 414(1-2):161-70. PMC: 3147252. DOI: 10.1016/j.ijpharm.2011.05.030. View

18.

Haley B, Frenkel E . Nanoparticles for drug delivery in cancer treatment. Urol Oncol. 2008; 26(1):57-64. DOI: 10.1016/j.urolonc.2007.03.015. View

19.

Dariva C, Coelho J, Serra A . Near infrared light-triggered nanoparticles using singlet oxygen photocleavage for drug delivery systems. J Control Release. 2018; 294:337-354. DOI: 10.1016/j.jconrel.2018.12.042. View

20.

Evans E, Bugga P, Asthana V, Drezek R . Metallic Nanoparticles for Cancer Immunotherapy. Mater Today (Kidlington). 2018; 21(6):673-685. PMC: 6124314. DOI: 10.1016/j.mattod.2017.11.022. View